Marker Therapeutics Inc (MRKR) earnings · rev $3.5M
These earnings events as JSON? API free 100/dayMarker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
This MRKR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported MRKR revenue for 2025-12-31 was $3.5M. Net income was -$12.2M. Revenue was down 46.2% from 2024-12-31 to 2025-12-31. MRKR currently screens at market cap $25.3M.
When the next MRKR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 46.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full MRKR research stays on the stock page; the tape stays on the quote page.
MRKR earnings FAQ
What are MRKR's latest revenue and net income?
Latest cached Marker Therapeutics Inc (MRKR) revenue for Dec 31, 2025 was $3.5M. Net income was -$12.2M. Statements: https://lician.com/financials/mrkr
What is MRKR's latest diluted EPS?
Latest cached Marker Therapeutics Inc (MRKR) diluted EPS for Dec 31, 2025 was -$0.79.
What period does the latest MRKR earnings print cover?
The latest cached Marker Therapeutics Inc (MRKR) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did MRKR revenue change from the prior cached period?
Cached Marker Therapeutics Inc (MRKR) revenue was down 46.2% from $6.6M (Dec 31, 2024) to $3.5M (Dec 31, 2025). Statements: https://lician.com/financials/mrkr
Where are MRKR earnings listed?
Cached earnings facts for Marker Therapeutics Inc (MRKR) are listed at https://lician.com/earnings/mrkr. Statements: https://lician.com/financials/mrkr
Not investment advice.